HeartFlow said yesterday that it won FDA clearance for its Planner tool for coronary artery disease intervention. The Redwood City, Calif.-based company developed FFRct, which works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing changes in flow across coronary lesions. The Planner virtual […]
HeartFlow
HeartFlow adds another $65m
HeartFlow added another $65 million to its coffers for the heart function analysis it developed. Redwood City, Calif.-based HeartFlow, which developed the FFRct fractional flow reserve analysis, said it hopes to raise another $35 million in the equity round. Nine unnamed investors participated, with the first sale occurring June 11,HeartFlow said in a regulatory filing. […]
HeartFlow taps ex-Beaver-Visitec CEO Mead as chief exec | Personnel Moves – May 28, 2019
HeartFlow said today that it named former Beaver-Visitec prez & CEO Dana Mead, Jr., as its new president and CEO, replacing current prez & CEO Dr. John Stevens, who will continue to serve on the board as chair. Prior to joining Beaver-Visitec, Mead served as a strategic advisor and partner in Kleiner Perkins Caufield & […]
Artificial intelligence and medicine: Is it overhyped?
Artificial intelligence raises exciting possibilities for healthcare, but are companies promising more than they can deliver? AI could possibly fuel the future of medtech, enabling such thrilling innovations as implanted devices that instantly react to minute changes, software that can identify the best treatment options for individuals facing life-threatening conditions and fully-functioning autonomous surgical systems. […]
HeartFlow publishes findings from consumer survey
HeartFlow this week published the findings of a 1,500-person consumer survey, reporting that just 29% of respondents knew that heart disease is the No. 1 cause of death among adults in the U.S. Half of the survey’s participants said that breast cancer is the leading cause of death among women, rather than heart disease. “We […]
HeartFlow wins Japanese reimbursement for FFRct analysis
HeartFlow said yesterday that it won reimbursement coverage from the Japanese Ministry of Health, Labor and Welfare for its HeartFlow FFRct fractional flow reserve analysis. The Redwood City, Calif.-based company said that it has already received approval from the Japanese Pharmaceuticals and Medical Devices Agency, and that reimbursement will go into effect beginning on December 1. […]
HeartFlow touts registry study, large hospital trial data
HeartFlow this week released data from two studies of its HeartFlow fractional flow reserve FFRct analysis system, touting that the system allows for the more effective differentiation of patients who need coronary stenting or bypass surgery and those who can be managed on medications alone. HeartFlow’s FFRct technology works by taking the data from a standard CT […]
HeartFlow wins UnitedHealthcare coverage for FFRct analysis
HeartFlow said today that it won reimbursement coverage from insurer UnitedHealthcare, which will now cover its HeartFlow FFRct fractional flow reserve analysis for its 45 million members. HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across coronary […]
HeartFlow inks collab research deal with Imperial College London
HeartFlow said on Wednesday it inked a collaborative research agreement deal with the Imperial College London for research in the areas of medical imaging and deep learning using the company’s FFRct technology. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing […]
HeartFlow closes $240m Series E
HeartFlow said today it closed a $240 million Series E round of financing, with funds slated to support commercial expansion and studies of its HeartFlow FFRct analysis system. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes […]
HeartFlow touts expanded insurer coverage for FFRct analysis
HeartFlow today touted that seven new insurers released positive medical policies supporting coverage for its HeartFlow FFRct analysis following a coronary computed tomography angiogram, expanding coverage to a total of 185 million patients. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D […]
